Incidence and prevalence of multiple endocrine neoplasia 2A in Denmark 1901–2014: a nationwide study

References

• WellsSAAsaSLDralleHRevised American Thyroid Association guidelines for the management of medullary thyroid carcinomaThyroid201525656761025810047
   PubMed Web of Science ®Google Scholar
• MachensALorenzKSekullaCMolecular epidemiology of multiple endocrine neoplasia 2: implications for RET screening in the new milleniumEur J Endocrinol2013168330731423211574
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPIncidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide studyEndocr Relat Cancer2017247L39L4228438782
   PubMed Web of Science ®Google Scholar
• ZnaczkoADonnellyDEMorrisonPJEpidemiology, clinical features, and genetics of multiple endocrine neoplasia type 2B in a complete populationOncologist201419121284128625355845
   PubMed Web of Science ®Google Scholar
• OpsahlEMBrauckhoffMSchlichtingEA nationwide study of multiple endocrine neoplasia type 2a in Norway: predictive and prognostic factors for the clinical course of medullary thyroid carcinomaThyroid20162691225123827400880
   PubMed Web of Science ®Google Scholar
• HøieJJørgensenOGStenwigAELangmarkFMedullary thyroid cancer in Norway. A 30-year experienceActa Chir Scand19881545–63393433420998
   PubMedGoogle Scholar
• MathiesenJSKroustrupJPVestergaardPDistribution of RET mutations in multiple endocrine neoplasia 2 in Denmark 1994-2014: a nationwide studyThyroid201727221522327809725
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPFounder effect of the RETC611Y mutation in multiple endocrine neoplasia 2A in Denmark: a nationwide studyThyroid201727121505151029020875
   PubMed Web of Science ®Google Scholar
• MathiesenJSKroustrupJPVestergaardPIncidence and prevalence of sporadic and hereditary MTC in Denmark 1960–2014: a nationwide studyEndocr Connect20187682983929760189
   PubMed Web of Science ®Google Scholar
• GjerstorffMLThe Danish Cancer RegistryScand J Public Health2011397 Suppl424521775350
   PubMed Web of Science ®Google Scholar
• LonderoSCMathiesenJSKrogdahlACompleteness and validity in a national clinical thyroid cancer database: DATHYRCACancer Epidemiol201438563363725132423
   PubMed Web of Science ®Google Scholar
• BjerregaardBLarsenOBThe Danish Pathology RegisterScand J Public Health2011397 Suppl727421775357
   PubMed Web of Science ®Google Scholar
• LyngeESandegaardJLReboljMThe Danish National Patient RegisterScand J Public Health2011397 Suppl303321775347
   PubMed Web of Science ®Google Scholar
• Nguyen-NielsenMSvenssonEVogelIEhrensteinVSundeLExisting data sources for clinical epidemiology: Danish registries for studies of medical genetic diseasesClin Epidemiol2013524926223966801
   PubMedGoogle Scholar
• MargrafRLCrockettDKKrautscheidPMMultiple endocrine neoplasia type 2 RET protooncogene database: repository of MEN2-associated RET sequence variation and reference for genotype/phenotype correlationsHum Mutat200930454855619177457
   PubMed Web of Science ®Google Scholar
• MathiesenJSHabraMABassettJHDRisk profile of the RET A883F germline mutation: an international collaborative studyJ Clin Endocrinol Metab201710262069207428323957
   PubMed Web of Science ®Google Scholar
• MathiesenJSStochholmKPoulsenPLVestergaardEMChristiansenPVestergaardPAggressive medullary thyroid carcinoma in a ten-year-old patient with multiple endocrine neoplasia 2B due to the A883F mutationThyroid201525113914025244518
   PubMed Web of Science ®Google Scholar
• MathiesenJSDossingHBenderLGodballeCMedullary thyroid carcinoma in a 10-month-old child with multiple endocrine neoplasia 2BUgeskr Laeger20141765apii V07130456
   Google Scholar
• Søndergaard PedersenJHSchaffalitzky de MuckadellOChoroidal metastases in multiple endocrine neoplasia type 2BActa Ophthalmol Scand200785112012117244227
   PubMedGoogle Scholar
• VestergaardPKroustrupJPRønneHEngCLaurbergPNeuromas in multiple endocrine neoplasia type 2A with a RET codon 611 mutationInt J Disabil Hum Dev1999113337
   Google Scholar
• HansenHSTorringHGodballeCJägerACNielsenFCIs thyroidectomy necessary in RET mutations carriers of the familial medullary thyroid carcinoma syndrome?Cancer200089486386710951350
   PubMed Web of Science ®Google Scholar
• EmmertsenKScreening for hereditary medullary cancer in DenmarkHenry Ford Hosp Med J19843242382436152458
   PubMedGoogle Scholar
• GodballeCJørgensenGGerdesAMKrogdahlASTybjaerg-HansenANielsenFCMedullary thyroid cancer: RET testing of an archival materialEur Arch Otorhinolaryngol2010267461361719823860
   PubMed Web of Science ®Google Scholar
• KjaerAPetersenCLPrimary diagnosis of multiple pheochromocytomas in the brother of a MEN-2 patient by simultaneous MIBG scintigraphy and low-dose computed tomographyClin Nucl Med2002271286887012607865
   PubMed Web of Science ®Google Scholar
• MathiesenJSvan Overeem HansenTRasmussenÅKNovel somatic RET mutation questioning the causality of the RET I852M germline sequence variant in multiple endocrine neoplasia 2AThyroid20172781103110428578594
   PubMed Web of Science ®Google Scholar
• BrandrupFOMedullary carcinoma of the thyroid gland. A review and report of 4 casesUgeskr Laeger197013294304375446571
   PubMedGoogle Scholar
• EmmertsenKMedullary thyroid carcinoma and calcitoninDan Med Bull1985321128
   Google Scholar
• EmmertsenKElbrøndONielsenHEFamilial medullary thyroid carcinoma in multiple endocrine neoplasia (MEN) IIa: diagnosis and problems in treatmentEur J Cancer Clin Oncol19821876456506127216
   PubMedGoogle Scholar
• EmmertsenKMelsenFMosekildeLAltered vitamin D metabolism and bone remodelling in patients with medullary thyroid carcinoma and hypercalcitoninemiaMetab Bone Dis Relat Res19824117237121251
   PubMedGoogle Scholar
• SchifterSWilliamsEDCraigRKHansenHHCalcitonin gene-related peptide and calcitonin in medullary thyroid carcinomaClin Endocrinol1986256703710
   Web of Science ®Google Scholar
• SchifterSCalcitonin gene-related peptide and calcitonin as tumour markers in MEN 2 family screeningClin Endocrinol1989303263270
   Web of Science ®Google Scholar
• SchifterSCalcitonin and PDN-21 as tumour markers in MEN-2 family screening for medullary thyroid carcinomaEur J Cancer1992282–33413451350454
   PubMed Web of Science ®Google Scholar
• TveteråsKPaulsenSMGreisenOJohansenJThyroid cancer in the county of North Jutland. Diagnosis, treatment and prognosisUgeskr Laeger199315520155715618316989
   PubMedGoogle Scholar
• HansenHSMedullary thyroid cancer–screeningUgeskr Laeger199415626389338968059474
   PubMedGoogle Scholar
• SchifterSJohnsenAHCalcitonin gene-related peptide in medullary thyroid carcinomas: characterization of molecular forms including the amidated C-terminusPeptides19941558979057984511
   PubMed Web of Science ®Google Scholar
• VestergaardPMultiple endocrine neoplasia type 2a and 2bUgeskr Laeger199615855905938607216
   PubMedGoogle Scholar
• KroustrupJPLaurbergPMadsenPHRapid MEN 2A gene carrier identification using primer-specific PCR amplificationScand J Clin Lab Invest199959864364710691056
   PubMed Web of Science ®Google Scholar
• VestergaardPJönssonALChristiansenPFrohnertJCan measurement of basal calcitonin replace the pentagastrin test?Ugeskr Laeger2008170413238324218940156
   PubMedGoogle Scholar
• ToledoRAHatakanaRLourençoDMComprehensive assessment of the disputed RET Y791F variant shows no association with medullary thyroid carcinoma susceptibilityEndocr Relat Cancer2015221657625425582
   PubMed Web of Science ®Google Scholar
• FanisPSkordisNFrangosSMultiple endocrine neoplasia 2 in Cyprus: evidence for a founder effectJ Endocrinol Invest201841101149115729396759
   PubMed Web of Science ®Google Scholar
• CunhaLLLindseySCFrançaMIEvidence for the founder effect of RET533 as the common Greek and Brazilian ancestor spreading multiple endocrine neoplasia 2AEur J Endocrinol2017176551551928137737
   PubMed Web of Science ®Google Scholar
• PinnaGOrgianaGRiolaARET proto-oncogene in Sardinia: V804M is the most frequent mutation and may be associated with FMTC/MEN-2A phenotypeThyroid200717210110417316110
   PubMed Web of Science ®Google Scholar
• GrothKAHoveHKyhlKPrevalence, incidence, and age at diagnosis in Marfan SyndromeOrphanet J Rare Dis20151015326631233
   PubMed Web of Science ®Google Scholar